Cargando…

Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke

INTRODUCTION/RATIONALE: In chronic obstructive pulmonary disease (COPD), defective macrophage phagocytic clearance of cells undergoing apoptosis by efferocytosis may lead to secondary necrosis of the uncleared cells and contribute to airway inflammation. The precise mechanisms for this phenomenon re...

Descripción completa

Detalles Bibliográficos
Autores principales: Asare, Patrick F., Tran, Hai B., Hurtado, Plinio R., Perkins, Griffith B., Nguyen, Phan, Jersmann, Hubertus, Roscioli, Eugene, Hodge, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647217/
https://www.ncbi.nlm.nih.gov/pubmed/34852704
http://dx.doi.org/10.1177/17534666211039769
_version_ 1784610568293842944
author Asare, Patrick F.
Tran, Hai B.
Hurtado, Plinio R.
Perkins, Griffith B.
Nguyen, Phan
Jersmann, Hubertus
Roscioli, Eugene
Hodge, Sandra
author_facet Asare, Patrick F.
Tran, Hai B.
Hurtado, Plinio R.
Perkins, Griffith B.
Nguyen, Phan
Jersmann, Hubertus
Roscioli, Eugene
Hodge, Sandra
author_sort Asare, Patrick F.
collection PubMed
description INTRODUCTION/RATIONALE: In chronic obstructive pulmonary disease (COPD), defective macrophage phagocytic clearance of cells undergoing apoptosis by efferocytosis may lead to secondary necrosis of the uncleared cells and contribute to airway inflammation. The precise mechanisms for this phenomenon remain unknown. LC3-associated phagocytosis (LAP) is indispensable for effective efferocytosis. We hypothesized that cigarette smoke inhibits the regulators of LAP pathway, potentially contributing to the chronic airways inflammation associated with COPD. METHODS: Bronchoalveolar (BAL)-derived alveolar macrophages, lung tissue macrophages obtained from lung resection surgery, and monocyte-derived macrophages (MDM) were prepared from COPD patients and control participants. Lung/airway samples from mice chronically exposed to cigarette smoke were also investigated. Differentiated THP-1 cells were exposed to cigarette smoke extract (CSE). The LAP pathway including Rubicon, as an essential regulator of LAP, efferocytosis and inflammation was examined using western blot, ELISA, flow cytometry, and/or immunofluorescence. RESULTS: Rubicon was significantly depleted in COPD alveolar macrophages compared with non-COPD control macrophages. Rubicon protein in alveolar macrophages of cigarette smoke-exposed mice and cigarette smoke-exposed MDM and THP-1 was decreased with a concomitant impairment of efferocytosis. We also noted increased expression of LC3 which is critical for LAP pathway in COPD and THP-1 macrophages. Furthermore, THP-1 macrophages exposed to cigarette smoke extract exhibited higher levels of other key components of LAP pathway including Atg5 and TIM-4. There was a strong positive correlation between Rubicon protein expression and efferocytosis. CONCLUSION: LAP is a requisite for effective efferocytosis and an appropriate inflammatory response, which is impaired by Rubicon deficiency. Our findings suggest dysregulated LAP due to reduced Rubicon as a result of CSE exposure. This phenomenon could lead to a failure of macrophages to effectively process phagosomes containing apoptotic cells during efferocytosis. Restoring Rubicon protein expression has unrecognized therapeutic potential in the context of disease-related modifications caused by exposure to cigarette smoke.
format Online
Article
Text
id pubmed-8647217
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86472172021-12-07 Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke Asare, Patrick F. Tran, Hai B. Hurtado, Plinio R. Perkins, Griffith B. Nguyen, Phan Jersmann, Hubertus Roscioli, Eugene Hodge, Sandra Ther Adv Respir Dis Original Research INTRODUCTION/RATIONALE: In chronic obstructive pulmonary disease (COPD), defective macrophage phagocytic clearance of cells undergoing apoptosis by efferocytosis may lead to secondary necrosis of the uncleared cells and contribute to airway inflammation. The precise mechanisms for this phenomenon remain unknown. LC3-associated phagocytosis (LAP) is indispensable for effective efferocytosis. We hypothesized that cigarette smoke inhibits the regulators of LAP pathway, potentially contributing to the chronic airways inflammation associated with COPD. METHODS: Bronchoalveolar (BAL)-derived alveolar macrophages, lung tissue macrophages obtained from lung resection surgery, and monocyte-derived macrophages (MDM) were prepared from COPD patients and control participants. Lung/airway samples from mice chronically exposed to cigarette smoke were also investigated. Differentiated THP-1 cells were exposed to cigarette smoke extract (CSE). The LAP pathway including Rubicon, as an essential regulator of LAP, efferocytosis and inflammation was examined using western blot, ELISA, flow cytometry, and/or immunofluorescence. RESULTS: Rubicon was significantly depleted in COPD alveolar macrophages compared with non-COPD control macrophages. Rubicon protein in alveolar macrophages of cigarette smoke-exposed mice and cigarette smoke-exposed MDM and THP-1 was decreased with a concomitant impairment of efferocytosis. We also noted increased expression of LC3 which is critical for LAP pathway in COPD and THP-1 macrophages. Furthermore, THP-1 macrophages exposed to cigarette smoke extract exhibited higher levels of other key components of LAP pathway including Atg5 and TIM-4. There was a strong positive correlation between Rubicon protein expression and efferocytosis. CONCLUSION: LAP is a requisite for effective efferocytosis and an appropriate inflammatory response, which is impaired by Rubicon deficiency. Our findings suggest dysregulated LAP due to reduced Rubicon as a result of CSE exposure. This phenomenon could lead to a failure of macrophages to effectively process phagosomes containing apoptotic cells during efferocytosis. Restoring Rubicon protein expression has unrecognized therapeutic potential in the context of disease-related modifications caused by exposure to cigarette smoke. SAGE Publications 2021-12-02 /pmc/articles/PMC8647217/ /pubmed/34852704 http://dx.doi.org/10.1177/17534666211039769 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Asare, Patrick F.
Tran, Hai B.
Hurtado, Plinio R.
Perkins, Griffith B.
Nguyen, Phan
Jersmann, Hubertus
Roscioli, Eugene
Hodge, Sandra
Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
title Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
title_full Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
title_fullStr Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
title_full_unstemmed Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
title_short Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
title_sort inhibition of lc3-associated phagocytosis in copd and in response to cigarette smoke
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647217/
https://www.ncbi.nlm.nih.gov/pubmed/34852704
http://dx.doi.org/10.1177/17534666211039769
work_keys_str_mv AT asarepatrickf inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke
AT tranhaib inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke
AT hurtadoplinior inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke
AT perkinsgriffithb inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke
AT nguyenphan inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke
AT jersmannhubertus inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke
AT rosciolieugene inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke
AT hodgesandra inhibitionoflc3associatedphagocytosisincopdandinresponsetocigarettesmoke